A Phase 1b/2, randomized, double-blind, placebo-controlled, multi-center study of STMC-103H in neonates and infants at high-risk for developing allergic disease

Is this Study for You?

Let's Get Started!

Details
Age

Child

Type of Study

Treatment

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Matthew Greenhawt,  MD

Matthew Greenhawt, MD

Study ID

Protocol Number: 20-2925

More information available at ClinicalTrials.gov: NCT05003804

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers